 |
인쇄하기
취소
|
Diabetes drug market in transition
Handok Pharmaceutical’s Amaryl kept its number 1 ranking in local diabetes drug market, but struggles this year against Merck’s Januvia (sitagliptin) which succeeded in overtaking the top position in October.
Januvia’s October sales recorded 5.7 billion won, exceeding Amaryl sales of 5.3 billion won.
Januvia is the newest class of agents to treat this disease, the dipeptidyl peptidase-IV ...
Januvia’s October sales recorded 5.7 billion won, exceeding Amaryl sales of 5.3 billion won.
Januvia is the newest class of agents to treat this disease, the dipeptidyl peptidase-IV ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.